Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Feb 24 | LYEL Lyell Immunopharma | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 48,928 |
9 Feb 24 | LYEL Lyell Immunopharma | Stock Option Common Stock | Grant | Acquire A | No | No | 1.8 | 400,000 | 720.00 k | 400,000 |
16 Nov 23 | LYEL Lyell Immunopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.98 | 700,000 | 4.19 mm | 0 |
16 Nov 23 | LYEL Lyell Immunopharma | Stock Option Common Stock | Grant | Acquire A | No | No | 1.87 | 700,000 | 1.31 mm | 700,000 |
16 Nov 23 | LYEL Lyell Immunopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 12.67 | 85,000 | 1.08 mm | 0 |
16 Nov 23 | LYEL Lyell Immunopharma | Stock Option Common Stock | Grant | Acquire A | No | No | 1.87 | 85,000 | 158.95 k | 85,000 |
16 Nov 23 | LYEL Lyell Immunopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.24 | 100,000 | 624.00 k | 0 |
16 Nov 23 | LYEL Lyell Immunopharma | Stock Option Common Stock | Grant | Acquire A | No | No | 1.87 | 100,000 | 187.00 k | 100,000 |
16 Nov 23 | LYEL Lyell Immunopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.96 | 450,000 | 2.68 mm | 0 |
16 Nov 23 | LYEL Lyell Immunopharma | Stock Option Common Stock | Grant | Acquire A | No | No | 1.87 | 450,000 | 841.50 k | 450,000 |